Spyre Therapeutics Inc (SYRE) — institutional ownership

278 funds reported holding Spyre Therapeutics Inc in their latest 13F filings, worth $8.85B in total (CUSIP 00773J202).

Largest holders

1. FMR LLC — $1.16B
2. BlackRock, Inc. (BLK) — $578M
3. PERCEPTIVE ADVISORS LLC — $383M
4. RTW INVESTMENTS, LP — $377M
5. Paradigm Biocapital Advisors LP — $341M
6. VANGUARD CAPITAL MANAGEMENT LLC — $306M
7. STATE STREET CORP (STT, STT-PG) — $271M
8. VR Adviser, LLC — $265M
9. PRICE T ROWE ASSOCIATES INC /MD/ — $263M
10. DRIEHAUS CAPITAL MANAGEMENT LLC — $249M

Famous investors holding it

• Izzy Englander portfolio (Millennium Management)
• Ken Griffin portfolio (Citadel Advisors)
• D. E. Shaw portfolio (D. E. Shaw & Co.)
• Two Sigma portfolio (Two Sigma Investments)

Insider buying and selling at Spyre Therapeutics Inc

Who owns the most SYRE stock?

The largest institutional holders in the latest 13F filings are FMR LLC ($1.16B), BlackRock, Inc. (BLK) ($578M), PERCEPTIVE ADVISORS LLC ($383M).

How many funds own SYRE?

278 funds reported holding it, worth $8.85B in total.